St Jude plans $500m share repurchase
This article was originally published in Clinica
Executive Summary
St Jude Medical has announced plans for a $500m share buy-back programme. The repurchases will be carried out through various transactions in both the public and private financing markets. The repurchased shares will be available for general corporate purposes, including offsetting dilution and other equity-based employee benefit plans. St Paul, Minnesota-based St Jude had around 330 million shares of common stock outstanding as of 1 August.